Free Trial
→ Get Your Bank Account “Fed Invasion” Ready with THESE 4 Simple Steps (From Weiss Ratings) (Ad) Buy ENTO Stock  Free ENTO Stock Alerts

Entero Therapeutics (ENTO) SEC Filings & 10K Form

Entero Therapeutics logo
$0.38 0.00 (-0.73%)
Closing price 04/17/2025 04:00 PM Eastern
Extended Trading
$0.37 -0.01 (-1.64%)
As of 04/17/2025 06:13 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.
Compare

Recent Entero Therapeutics SEC Filings

Export to Excel
DateFilerForm TypeView
04/14/2025
3:15 PM		Entero Therapeutics, Inc. (Filer)
Entero Therapeutics, Inc. (Filer)
Entero Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/09/2025
4:21 PM		Entero Therapeutics, Inc. (Filer)
Entero Therapeutics, Inc. (Filer)
Entero Therapeutics (Filer)
Form 10-K/A
04/01/2025
10:06 AM		Entero Therapeutics, Inc. (Filer)
Entero Therapeutics, Inc. (Filer)
Entero Therapeutics (Filer)
Form NT 10-K
02/13/2025
3:59 PM		Entero Therapeutics, Inc. (Issuer)
Entero Therapeutics, Inc. (Issuer)
Entero Therapeutics (Issuer)
Paolone Richard (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
02/13/2025
4:00 PM		Corbett Eric (Reporting)
Entero Therapeutics, Inc. (Issuer)
Entero Therapeutics, Inc. (Issuer)
Entero Therapeutics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
02/13/2025
4:02 PM		Entero Therapeutics, Inc. (Issuer)
Entero Therapeutics, Inc. (Issuer)
Entero Therapeutics (Issuer)
Uppal Manpreet (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
02/06/2025
3:31 PM		Entero Therapeutics, Inc. (Filer)
Entero Therapeutics, Inc. (Filer)
Entero Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/13/2025
3:18 PM		Entero Therapeutics, Inc. (Filer)
Entero Therapeutics, Inc. (Filer)
Entero Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/08/2025
3:23 PM		Entero Therapeutics, Inc. (Issuer)
Entero Therapeutics, Inc. (Issuer)
Entero Therapeutics (Issuer)
Romano Sarah (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/13/2024
6:15 AM		Entero Therapeutics, Inc. (Filer)
Entero Therapeutics, Inc. (Filer)
Entero Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/13/2024
6:00 AM		Entero Therapeutics, Inc. (Filer)
Entero Therapeutics, Inc. (Filer)
Entero Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/21/2024
6:31 AM		Entero Therapeutics, Inc. (Filer)
Entero Therapeutics, Inc. (Filer)
Entero Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
10/10/2024
4:00 PM		Entero Therapeutics, Inc. (Issuer)
Entero Therapeutics, Inc. (Issuer)
Entero Therapeutics (Issuer)
Romano Sarah (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/11/2024
4:10 PM		Entero Therapeutics, Inc. (Filer)
Entero Therapeutics, Inc. (Filer)
Entero Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/10/2024
6:00 AM		Entero Therapeutics, Inc. (Filer)
Entero Therapeutics, Inc. (Filer)
Entero Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/29/2024
3:05 PM		Entero Therapeutics, Inc. (Filer)
Entero Therapeutics, Inc. (Filer)
Entero Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/23/2024
4:00 PM		Entero Therapeutics, Inc. (Filer)
Entero Therapeutics, Inc. (Filer)
Entero Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/22/2024
4:28 PM		Entero Therapeutics, Inc. (Filer)
Entero Therapeutics, Inc. (Filer)
Entero Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/15/2024
7:00 AM		Entero Therapeutics, Inc. (Filer)
Entero Therapeutics, Inc. (Filer)
Entero Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/15/2024
7:05 AM		Entero Therapeutics, Inc. (Filer)
Entero Therapeutics, Inc. (Filer)
Entero Therapeutics (Filer)
Form NT 10-Q
08/14/2024
8:46 PM		Entero Therapeutics, Inc. (Issuer)
Entero Therapeutics, Inc. (Issuer)
Entero Therapeutics (Issuer)
Ramdeen Timothy R. (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
08/07/2024
4:20 PM		Entero Therapeutics, Inc. (Filer)
Entero Therapeutics, Inc. (Filer)
Entero Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/31/2024
9:54 AM		Entero Therapeutics, Inc. (Filer)
Entero Therapeutics, Inc. (Filer)
Entero Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/26/2024
3:16 PM		Entero Therapeutics, Inc. (Filer)
Entero Therapeutics, Inc. (Filer)
Entero Therapeutics (Filer)
Form S-3
Registration statement under Securities Act of 1933  
07/23/2024
3:05 PM		Entero Therapeutics, Inc. (Filer)
Entero Therapeutics, Inc. (Filer)
Entero Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/11/2024
7:00 AM		Entero Therapeutics, Inc. (Filer)
Entero Therapeutics, Inc. (Filer)
Entero Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/03/2024
1:33 PM		Entero Therapeutics, Inc. (Issuer)
Entero Therapeutics, Inc. (Issuer)
Entero Therapeutics (Issuer)
SAPIRSTEIN JAMES (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/03/2024
1:34 PM		Entero Therapeutics, Inc. (Issuer)
Entero Therapeutics, Inc. (Issuer)
Entero Therapeutics (Issuer)
Romano Sarah (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/24/2024
7:03 AM		Entero Therapeutics, Inc. (Filer)
Entero Therapeutics, Inc. (Filer)
Entero Therapeutics (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
06/20/2024
3:30 PM		Entero Therapeutics, Inc. (Filer)
Entero Therapeutics, Inc. (Filer)
Entero Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/17/2024
4:23 PM		Entero Therapeutics, Inc. (Filer)
Entero Therapeutics, Inc. (Filer)
Entero Therapeutics (Filer)
Form PRER14A
06/14/2024
4:15 PM		Entero Therapeutics, Inc. (Filer)
Entero Therapeutics, Inc. (Filer)
Entero Therapeutics (Filer)
Form 424B3
06/12/2024
5:23 PM		Entero Therapeutics, Inc. (Issuer)
Entero Therapeutics, Inc. (Issuer)
Entero Therapeutics (Issuer)
KHOSLA CHAITAN PHD (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/10/2024
11:15 PM		Entero Therapeutics, Inc. (Filer)
Entero Therapeutics, Inc. (Filer)
Entero Therapeutics (Filer)
Form EFFECT
06/05/2024
4:15 PM		Entero Therapeutics, Inc. (Filer)
Entero Therapeutics, Inc. (Filer)
Entero Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/31/2024
4:25 PM		Entero Therapeutics, Inc. (Filer)
Entero Therapeutics, Inc. (Filer)
Entero Therapeutics (Filer)
Form S-3
Registration statement under Securities Act of 1933  
05/30/2024
4:18 PM		Entero Therapeutics, Inc. (Filer)
Entero Therapeutics, Inc. (Filer)
Entero Therapeutics (Filer)
Form 8-K/A
05/30/2024
4:32 PM		Entero Therapeutics, Inc. (Filer)
Entero Therapeutics, Inc. (Filer)
Entero Therapeutics (Filer)
Form DEFA14A
05/16/2024
6:16 AM		First Wave BioPharma, Inc. (Filer)
First Wave BioPharma, Inc. (Filer)
Entero Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/14/2024
4:26 PM		First Wave BioPharma, Inc. (Filer)
First Wave BioPharma, Inc. (Filer)
Entero Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/13/2024
4:26 PM		First Wave BioPharma, Inc. (Filer)
First Wave BioPharma, Inc. (Filer)
Entero Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
Trump to unlock 15-figure fortune for America (May 3rd) ? (Ad)

We were shown this map by former Presidential Advisor, Jim Rickards, one of the most politically connected men in America. Rickards has spent his fifty-year career in the innermost circles of the U.S. government and banking. And he believes Trump could soon release this frozen asset to the public.

But something even more spectacular is bound to happen. And those who know what to expect could make
05/13/2024
3:59 PM		First Wave BioPharma, Inc. (Filer)
First Wave BioPharma, Inc. (Filer)
Entero Therapeutics (Filer)
Form 424B5
05/08/2024
4:16 PM		First Wave BioPharma, Inc. (Filer)
First Wave BioPharma, Inc. (Filer)
Entero Therapeutics (Filer)
Form 8-K/A
(Data available from 1/1/2016 forward)


Related Companies and Tools

Related Companies
SEC Filings Tools

This page (NASDAQ:ENTO) was last updated on 4/21/2025 by MarketBeat.com Staff
From Our Partners
Elon Set to Shock the World by May 1st ?
Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...
Brownstone Research | Sponsored
[Action Required] Claim Your FREE IRS Loophole Guide
This shouldn't surprise anyone who's been paying attention, but... Pres. Trump may be about to unleash the ...
Colonial Metals | Sponsored
Now I look stupid. Real stupid...
I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...
Porter & Company | Sponsored
Get Your Bank Account “Fed Invasion” Ready with THESE 4 Simple Steps
Starting as soon as a few months from now, the United States government will make a sweeping change to bank ac...
Weiss Ratings | Sponsored
URGENT: This Altcoin Opportunity Won’t Wait – Act Now
My friends Joel and Adam have a simple motto: "For us, it's always a bull market." That’s because their 92%...
Crypto Swap Profits | Sponsored
$2 Trillion Disappears Because of Fed's Secretive New Move
$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...
Stansberry Research | Sponsored
Altucher: Turn $900 into $108,000 in just 12 months?
We are entering the final Trump Bump of our lives. But the biggest returns will not be in the stock market.
Paradigm Press | Sponsored
Gold Hits New Highs as Global Markets Spiral
When Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...
Premier Gold Co | Sponsored